1. World Health Organisation (2011) Antiretroviral therapy (ART) coverage among all age groups. Available: http://www.who.int/gho/hiv/epidemic_response/ART_text/en/index.html. Accessed 2013 Oct 1.
2. World Health Organisation (2004) Scaling up antiretroviral therapy in Resource-limited settings: treatment guidelines for a public health approach: 2003 Revision. Available: http://www.who.int/3by5/publications/documents/arv_guidelines/en/. Accessed 2013 Oct 1.
3. World Health Organisation. The Treatment 2.0 framework for action: catalysing the next phase of treatment, care and support. Geneva, WHO/UNAIDS, 2011. Available: http://whqlibdoc.who.int/publications/2011/9789241501934_eng.pdf. Accessed 2013 Nov 21.
4. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study;J Fellay;Lancet,2001
5. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve pateints. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients;A d'Arminio Monteforte;AIDS,2000